Hemoglobin Electrophoresis Cannot Be Normal in True Sickle Cell Anemia
If hemoglobin electrophoresis appears "normal" in a patient with suspected sickle cell disease, the patient either does not have sickle cell disease, the test was performed incorrectly, or the patient was recently heavily transfused.
Understanding the Diagnostic Reality
Hemoglobin electrophoresis is highly sensitive, reliable, and reproducible for detecting HbS in all forms of sickle cell disease 1. A truly normal result (showing only HbA with no HbS) definitively excludes sickle cell disease in non-transfused patients.
Key Diagnostic Principles
Standard hemoglobin electrophoresis patterns in sickle cell disease:
- HbSS (Sickle Cell Anemia): 80-95% HbS, 0% HbA, 5-15% HbF 1
- HbSC Disease: 50-55% HbS, 40-45% HbC, 0% HbA 1
- HbS β⁰-thalassemia: 80-90% HbS, 0% HbA 1
- HbS β⁺-thalassemia: 70-80% HbS, 10-25% HbA 1
The absence of HbS on electrophoresis rules out sickle cell disease.
Critical Diagnostic Pitfalls
1. Recent Blood Transfusion
The most important cause of a falsely "normal" result is recent transfusion. Transfused normal red blood cells will show HbA on electrophoresis, potentially masking the patient's underlying HbS 1. The sickle solubility test can also give false negative results in heavily transfused patients 1.
2. Neonatal Testing Limitations
In newborns, the sickle solubility test may give false negative results due to high HbF levels 1. However, proper hemoglobin electrophoresis using HPLC, capillary electrophoresis, or mass spectrometry will still detect HbS even in neonates 1.
3. Inadequate Testing Method
A positive sickle solubility test alone should never be used in isolation, as it does not differentiate between sickle cell trait (HbAS), sickle cell disease (HbSS), or compound heterozygous states 1. The diagnosis of HbS should never be accepted if not confirmed by a second, more specific test 2.
Recommended Diagnostic Algorithm
When sickle cell disease is suspected but initial testing appears normal:
Verify transfusion history immediately - If the patient received transfusions within the past 3-4 months, results may be unreliable
Confirm the testing method used:
Perform confirmatory testing:
If still uncertain, proceed to molecular testing:
- DNA analysis for HbS mutation (HBB:c.20A>T) 3
- This is definitive and unaffected by transfusion status
Clinical Context Matters
Red flags that should prompt further investigation despite "normal" electrophoresis:
- Chronic hemolytic anemia with baseline Hb 60-90 g/L 1
- Recurrent painful vaso-occlusive crises 1
- Family history of sickle cell disease 4
- Ethnicity: African, Caribbean, Middle Eastern, Indian, or Mediterranean descent 1
- Evidence of end-organ damage (stroke, pulmonary hypertension, avascular necrosis) 1
In patients with these features and "normal" electrophoresis, the most likely explanations are:
- Recent transfusion masking the diagnosis
- Sickle cell trait (HbAS) rather than disease - shows 30-40% HbS, 55-65% HbA 1
- Technical error in specimen handling or analysis
Important Distinction: Sickle Cell Trait vs. Disease
Sickle cell trait (HbAS) is a benign carrier state showing 30-40% HbS on electrophoresis 1. This is NOT sickle cell disease and only becomes clinically relevant at extremes of physiology (severe sepsis, extreme dehydration) 1. Do not confuse trait with disease - patients with trait have predominantly HbA and are generally asymptomatic.
Bottom Line
A normal hemoglobin electrophoresis showing only HbA with no HbS effectively excludes sickle cell disease in a non-transfused patient. If clinical suspicion remains high, investigate transfusion history, verify testing methodology, and consider molecular confirmation. The technology is robust - trust the test when performed correctly 1, 3.